期刊文献+

加味升降散对T2DM并血脂异常患者调脂作用临床研究 被引量:1

Clinical Study on the Lipid-reducing Effect of Jiaweishengjiang Powder on T2DM and Dyslipidemia Patients
下载PDF
导出
摘要 目的:观察加味升降散对2型糖尿病(T2DM)并血脂异常患者调脂作用临床观察。方法:将90例T2DM合并血脂异常患者,随机分为3组,加味升降散治疗组、血脂平对照组和空白对照组,每组各30例。3组均治疗2个月,治疗前后观察临床表现、血脂、游离脂肪酸、胰岛素等水平。结果:(1)治疗组治疗后血脂各项指标治疗前后自身比较(P均<0.05),其中甘油三酯治疗前后相比有明显差异(P<0.01)。治疗组其中医证候的改善以及综合疗效有优于血脂平对照组之趋势。(2)治疗组治疗前后游离脂肪酸水平自身比较有明显差异(P<0.01)。(3)治疗组胰岛素水平自身比较有差异(P均<0.05)。经治疗后有7例患者其高胰岛素血症得到不同程度改善。(4)试验过程中,治疗组有2例患者在治疗初期出现轻度腹泻,考虑与大黄有关,其中1例减少大黄剂量,1例继续原方治疗,腹泻症状均消失。结论:(1)中医升清降浊、化痰利湿、活血化瘀法治疗T2DM合并血脂异常有效。(2)本研究发现加味升降散对游离脂肪酸可能有一定的调节作用。(3)本研究发现加味升降散对T2DM患者胰岛素抵抗、高胰岛素血症可能有一定改善作用。(4)本方对于T2DM患者的调脂治疗安全有效。 Objective: To observe the lipid-reducing effect of Jiaweishengjiang Powder on T2DM and dyslipidemia patients.Methods: 90 TZDM and dyslipidemia patients were randomly divided into three groups,i.e.Jiaweishengjiang Powder group,lipids level control group and blank control group,30 patients per group.The patients of the 3 groups were treated for 2 months,and their clinical manifestations,blood lipids,free fatty acids and insulin level were observed before and after the treatment.Results:(1) The lipid indicators of the treatment group showed a significant difference(P<0.05) in its self-comparison in which the triglyceride of the patients showed more significant difference(P<0.01) before and after the treatment.TCM syndrome improvement and the integrated efficacy of the treatment group were superior to that of the lipids level control group.(2) The self-comparison of free fatty acid levels of the treatment group was significant difference(P<0.01) before and after the treatment.(3) The self-comparison of the insulin levels of the treatment group was differences(P<0.05).The hyperinsulinemia of 7 patients improved after the treatment at varying degrees.(4) In the test procedure,2 patients of the treatment group had mild diarrhea early in the treatment,probably related to rhubarb.One patient was treated with reduced rhubarb dose and another kept the original treatment.Their diarrhea symptoms disappeared.Conclusions:(1) TCM turbid-expelling,phlegm-reducing and activating boold circulation treatment has an extraordinary effect on the treatment of T2DM and dyslipidemia patients.(2) The study discovers Jiaweishengjiang Powder has a certain regulatory effect on the free fatty acids.(3) The study discovers Jiaweishengjiang Powder has a certain improvement for the insulin resistance and hyperinsulinemia of T2DM patients.(4) The prescription is safe and effective for the lipid-lowering of T2DM patients.
作者 杨娟 李雪梅
出处 《云南中医中药杂志》 2012年第9期12-15,1,共4页 Yunnan Journal of Traditional Chinese Medicine and Materia Medica
关键词 2型糖尿病 血脂异常 游离脂肪酸 T2DM diabetes,dyslipidemia,free fatty acids
  • 相关文献

参考文献7

二级参考文献54

  • 1郭建鹏,刘岩.高脂血症的中医论治及复方研究进展[J].时珍国医国药,2005,16(5):428-429. 被引量:6
  • 2赵坤元.高脂血症中医药研究进展[J].江苏中医药,2005,26(12):66-67. 被引量:9
  • 3郑琼莉,祝炜.高脂血症[M].北京:中国医药科技出版社,2007:1-6.
  • 4任洪波 刘莉 李杨 等.血稠清胶囊对痰瘀阻滞型高脂血症中医证候的影响.中国现代实用医杂志,2006,5(12):30-32.
  • 5Boden G, Cheung P, Stein TP et al.FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis[J]. Am J Physiol Endocrinol Metab,2002,283(1):E12-9.
  • 6Perseghin G, Scifo P, De Cobelli F et al.Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: A 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents[J].Diabetes,1999,48(8):1600-6.
  • 7Schmitz-Peiffer C, Craig DL, Biden TJ.Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate[J].J Biol Chem,1999,274(34):24202-10.
  • 8Boden G, Lebed B, Schatz M et al.Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects[J].Diabetes,2001,50(7):1612-7.
  • 9Pessin JE, Saltiel AR. Signaling pathways in insulin action:Molecular targets of insulin resistance[J].J Clin Invest,2000,106(2):165-9.
  • 10Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism[J].Nature,2001,414(6865):799-806.

共引文献103

同被引文献55

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部